v
Search
Advanced Search

Publications > Journals > Future Integrative Medicine > Article Full Text

  • OPEN ACCESS

Phytosynthesized Nanoparticles Against Viral Diseases: Current Updates

  • Mohammad K. Parvez*  and
  • Sarfaraz Ahmed
 Author information  Cite
Future Integrative Medicine   2023;2(1):32-35

doi: 10.14218/FIM.2022.00040

Abstract

Advancements in nanomedicine have effectively overcome the issues of solubility, absorption, and cytotoxicity of conventional drugs. In recent years, phytoproducts rich in bioactive constituents have been exploited as green-, herb-, or phytosynthesized metal or nonmetal nanocarriers. Of these, alkaloids, flavonoids, polyphenols, sterols, lignans, tannins, and saponins efficiently contribute to the enhanced stability of such nanocarriers or nanoparticles by reducing metal ions. In addition, phytosynthesized silver and gold nanoparticles have received much interest due to their less hazardous, eco-friendly, and cost-effective properties. Owing to these properties, phytosynthesized silver and gold nanoparticles also have been developed as effective antiviral drug delivery carriers against human immunodeficiency virus, herpes simplex virus, influenza virus, dengue virus, chikungunya virus, hepatitis B virus, bovine diarrhea virus, and foot and mouth disease virus infections. Although experimental studies have shown that such phytonanoparticles can inhibit viral replication in infected cells, the underlying mechanism of their antiviral activities is poorly understood. Importantly, compared to herbal antivirals or metal-based antiviral nanoparticles, the novel approach of phytosynthesis of antiviral nanoparticles seems to be in its infancy. In view of the emerging viral outbreaks and pandemics like coronavirus disease 2019, this area of drug research needs special attention.

Keywords

Nanotechnology, Herbal drugs, Phytosynthesized nanoparticles, Antiviral

Introduction

In modern research, nanotechnology has become an important field dealing with the synthetic strategies and manipulation of metallic or nonmetallic substances of <100 nm in size. The physical, chemical, and biological properties of such nanoparticles, either atom or molecule, can be controlled or changed in a fundamental way. The growing applications of nanoparticles are rapidly transforming numerous fields of research such as environmental science, chemical industries, electronics, optical devices, cosmetics, health care, and biomedical instruments, etc.1 Further, the application of nanobiotechnology requires hygienic, safe, and eco-friendly methods of synthesizing such nanoparticles. In view of this, the use of substances of biological origin, nonhazardous environmentally friendly solvents, and renewable materials have become key to the development of green-, herb-, or phytosynthesized nanoparticles.2,3 Phytosynthesis of nanoparticles includes the exploitation of various biological materials of bacterial, fungal, algal, or plant sources, collectively called as biogenic nanoparticles.4

Nanotechnology has emerged as a significant technology in biomedical science, including drug or gene delivery systems.5,6 In nanomedicine, this technology allows the development of new classes of bioactive macromolecules for their cellular or targeted delivery of therapeutic molecules for their enhanced bioavailability and activities.7

Nanoparticles or nanocarriers are nanoscale spacious structures (1–100 nm) of metallic or nonmetallic materials prepared as a powder, suspension, or colloidal form. The nanoparticles are morphologically classified on the basis of a high or low aspect ratio, where the former class includes tubes and wires, while the later class includes spherical, oval, or capsular nanostructures.8 Recently, nanoparticles have emerged as the preferred delivery system against important chronic and infectious diseases due to their properties, which reduce the cytotoxicity and side effects of some drugs. In addition, several biological substances such as albumin, gelatin, liposomes, polymers, metals, nonmetals, and phytoproducts have been developed to synthesize promising drug-delivery nanoparticles.9

Nanoparticles or carriers as drug delivery vehicles

A nanocarrier is a nanosized spacious vehicle for another substance such as a drug or therapeutic molecule. The most commonly used materials to synthesize such nanocarriers are lipid micelles, liposomes, protein polymers, carbon, silver, gold, etc. Because the human body contains mostly water, the materials used in therapeutic nanocarriers should allow the efficient delivery of both hydrophobic and hydrophilic drugs to the cells.10,11 Nonetheless, a potential problem with inorganic or synthetic nanocarriers is their unwanted toxicity if they accumulate in certain cell organelles compared to protein-based nanocarriers, which generally demonstrate less cytotoxicity.12 Furthermore, in nanomedicine, such nanocarriers are employed to deliver therapeutic agents to specifically targeted sites in a controlled manner. Nanomedicine manages the nanoparticle size, surface properties, and discharge of bioactive molecules to achieve their site-specific delivery and action under the optimum conditions. In contrast to nanoliposomes, polymeric nanoparticles have some precise advantages; for example, they help to enhance the stability of drugs and possess suitable controlled release in the body.13–15

Phytosynthesis of therapeutic nanoparticles

Although therapeutic herbs or phytoproducts can easily dissolve in nonpolar solvents, they are poorly soluble in water, resulting in their partial absorption when taken orally. In recent years, therefore, phytoproducts rich in bioactive constituents have been reported as green-, herb-, or phytosynthesized lipid, polymer, lipid–polymer hybrid, carbon, and silver or gold nanoparticles.8 Moreover, phytochemicals, such as alkaloids, flavonoids, polyphenols, sterols, lignans, tannins, and saponins effectively contribute to the reduction of gold and silver ions, thereby enhancing their stability. In addition, such phytosynthesized silver nanoparticles (AgNPs) or gold nanoparticles (AuNPs) have received much attention due to their less biohazardous, eco-friendly, and cost-effective properties.16 Furthermore, several recent studies have suggested that such phytosynthesized AuNPs can also act as effective antiviral drugs.17

In herbal medicine or phytotherapy research and development, phytosynthesized nanoparticles have gained much attention. Even though marginal or no side effects have made natural products a potential therapeutic alternative, there exist important issues of their poor delivery, solubility, permeability, bioavailability, instability, and metabolism. These restrictions can be overcome by their attachment with or encapsulation within appropriately studied and selected nanomaterials for their significant enhancement in the pharmacokinetics index.18,19 In view of this, the most important features for nanoparticle synthesis include the selection of phytoproducts, sustainable or eco-friendly solvent, a good reducing agent, and a safe or noncytotoxic material.20 In contrast to the chemical methods that are very costly and use hazardous chemicals,21 the phytosynthesized nanoparticles are safe, biocompatible, and environmentally friendly.22

For the biogenic synthesis of nanoparticles, the use of plant extracts is a very simple and easy process to synthesize metal or metal-oxide nanoparticles at a large scale compared to bacteria or fungi.4,20,23 Higher plants are a very rich source of bioactive phytoconstituents like alkaloids, flavonoids, saponins, steroids, tannins, and phenolic acids, which act as stabilizing and reducing agents for metal ions as well as inhibit their aggregation and agglomeration by nonhazardous means.24–26 Moreover, the phytosynthesis of nanoparticles based on biological precursors depends on various reaction parameters such as the solvent, temperature, pressure, and pH conditions. Also, while the type of plant product and its concentration affect the morphology of the herb-synthesized nanoparticles, the temperature and pH of the medium control their growth and size.27

Metabolism of phytonanoparticles

Bioactive phytochemicals have a high-water solubility but low absorption capacities due to their large molecular sizes that inefficiently permeate the cell membrane, resulting in poor bioavailability. Phytosynthesized nanoparticles have advanced due to their efficient targeted drug delivery without the further need for conjugating ligands; additionally, they demonstrate enhanced solubility, absorption, bioavailability, and safety.28–30 They have enhanced permeation through obstacles because of their nanosize as well as their increased retention time owing to poor lymphatic drainage.31 In targeting hepatocytes, though the in-vivo uptake of lipid-nanoparticles is limited, a reduction in the accumulation of antiviral siRNA vectors in sinusoidal endothelial cells, including hepatotoxicity, has been reported.32

Recent approaches with solid-lipid nanoparticles, liquid-crystal systems, precursor systems for liquid-crystals, or microemulsions with new substances having dissimilar properties in the same formulation could allow further alterations in their properties and behavior in a biological environment. Furthermore, other parameters like selectivity and efficacy, defending against thermal degradation or photodegradation, fewer side effects, and the controlled release of active constituents can be further improved before commercialization.33–35

Phytosynthesized antiviral nanoparticles

Viral diseases are among the most serious global public issues. In recent decades, several cases of viral epidemics and pandemics, notably, coronavirus disease 2019, have caused significant increases in mortality and morbidity rates worldwide.36,37 In addition to conventional drugs, several phytoproducts and isolated metabolites have been extensively reported for their antiviral properties against several viruses.38 Natural bioactive compounds have a high chemical diversity and biochemical specificity; therefore, exploring natural products could be an effective strategy to develop new and potential antiviral drugs.

In the past decade, ample of studies has reported that phytosynthesized metal nanoparticles like AuNPs can also inhibit human immunodeficiency virus, influenza virus, herpes simplex virus (HSV), chikungunya virus, hepatitis B virus, bovine diarrhea virus, foot-and-mouth disease virus.17 Notably, its further modifications or functionalization as multivalent-, tannic acid-, gallic acid-, or curcumin-AuNP also have been suggested for enhanced antiviral activities.39,40 The notable examples include Astragalus membranaceus-derived tannic acid-modified AgNPs against HSV;41Tinospora cordifolia, Phyllanthus niruri, and Andrographis paniculate extract-synthesized AgNPs against chikungunya virus;42Lampranthus coccineus and Malephora lutea extract-synthesized AuNPs against HSV, influenza virus, and hepatitis B virus;43 and Plumbago indica-synthesize zinc oxide nanoparticles against HSV (Table 1).41,43–47 Although further experimental studies have shown that such phytonanoparticles can inhibit viral replication in infected cells, the underlying mechanism of their antiviral activities is poorly understood.

Table 1

Synthesis of antiviral nanoparticles using various plant products.

Plant/productMetalVirusReference
Astragalus membranaceusAgHSV41
Lampranthus coccineusAgHSV-1, HAV-10, CoxB443
Malephora luteaAgHSV-1, HAV-10, CoxB443
Plumbago indicaZnHSV-144
Portulaca oleraceaSeHAV, Cox-B445
Cinnamomum cassiaAgInfluenza A subtype H7N346
Tinospora cordifoliaAgCKV47
Phyllanthus niruriAgCKV47
Andrographis paniculateAgCKV47
Cinnamon, curcumin, pepperSe2SInfluenza A subtype H1N1, HCoV-OC43.46

Future directions

Compared to conventional herbal antivirals or metal-based antiviral nanoparticles, the novel combined approach of plant-mediated synthesis of metal-based antiviral nanoparticles seems to be in its infancy. Therefore, in view of the emerging viral outbreaks and pandemics like coronavirus disease 2019, this area of research needs special attention towards the development of more effective, nonhazardous, biodegradable, and cost-effective antiviral drugs.

Conclusions

Nanomedicines employing different carrier materials have effectively resolved the issues of delivery, solubility, absorption, and cytotoxicity of conventional drugs. Therapeutic herbal or phytoproducts can easily dissolve in nonpolar solvents, but they are poorly soluble in water, resulting in partial absorption. Therefore, owing to their ability to efficiently reduce and stabilize metal ions, several herbal products or bioactive phytochemicals have been exploited as plant-mediated or phytosynthesized gold and silver nanoparticles, which are less biohazardous, eco-friendly, cost-effective, and easily scalable. Recently, phytosynthesized gold and silver nanoparticles have been developed as effective drug-delivery vehicles against infectious diseases, including pathogenic viruses.

Abbreviations

AgNPs: 

silver nanoparticles

AuNPs: 

gold nanoparticles

HSV: 

herpes simplex virus

Declarations

Acknowledgement

None.

Funding

None.

Conflict of interest

MKP has been an editorial board member of Future Integrative Medicine since November 2021. The other author reports no conflict of interests in this work.

Authors’ contributions

Conceptualization, literature search, data acquisition, and preparation of the first draft (MKP), literature search, data acquisition, and preparation of the final draft (SA), review and approval of the final manuscript (MKP and SA).

References

  1. Ahmed S, Ahmad M, Swami BL, Ikram S. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. J Adv Res 2016;7(1):17-28 View Article PubMed/NCBI
  2. Ahmad W, Ajay S, Krishna Kumar J, Gupta P. Green Synthesis of Photocatalytic TiO2 Nanoparticles for Potential Application in Photochemical Degradation of Ornidazole. J Inorg Organom Polym 2021;31:614-623 View Article
  3. Al-Zahrani S, Astudillo-Calderón S, Pintos B, Pérez-Urria E, Manzanera JA, Martín L, et al. Role of Synthetic Plant Extracts on the Production of Silver-Derived Nanoparticles. Plants (Basel) 2021;10(8):1671 View Article PubMed/NCBI
  4. Singh J, Dutta T, Kim KH, Rawat M, Samddar P, Kumar P. ‘Green’ synthesis of metals and their oxide nanoparticles: applications for environmental remediation. J Nanobiotechnology 2018;16(1):84 View Article PubMed/NCBI
  5. Nalwa HS. Handbook of Nanostructured Materials and Nanotechnology. Academic Press; 2000
  6. Poole CP, Owens FJ. Introduction to Nanotechnology. Wiley India (P.) Ltd.; 2010
  7. Pandey A, Pandey G. Usefulness of nanotechnology for herbal medicines. Plant Arch 2013;13(2):617-621
  8. Yadav D, Suri S, Choudhary AA, Sikander M, Hemant BNM. Novel approach: herbal remedies and natural products in pharmaceutical science as nano-drug delivery systems. Int J Pharm Tech 2011;3(3):3092-3116
  9. De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. Int J Nanomedicine 2008;3(2):133-149 View Article PubMed/NCBI
  10. Gupta VK, Karar PK, Ramesh S, Misra SP, Gupta A. Nanoparticle formulation for hydrophilic and hydrophobic drugs. Int J Pharm Sci Res 2010;1(2):163-169
  11. Aw MS, Addai-Mensah J, Losic D. A multi-drug delivery system with sequential release using titania nanotube arrays. Chem Commun (Camb) 2012;48(27):3348-3350 View Article PubMed/NCBI
  12. Elzoghby AO, Samy WM, Elgindy NA. Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release 2012;161(1):38-49 View Article PubMed/NCBI
  13. Velavan P, Karuppusamy C, Venkatesan P. Nanoparticles as Drug Delivery Systems. J Pharm Sci Res 2015;7:1118-1122
  14. Vila A, Sánchez A, Tobío M, Calvo P, Alonso MJ. Design of biodegradable particles for protein delivery. J Control Release 2002;78(1-3):15-24 View Article PubMed/NCBI
  15. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003;86(1):33-48 View Article PubMed/NCBI
  16. Vanaja M, Paulkumar K, Gnanajobitha G, Rajeshkumar S, Malarkodi C, Annadurai G. Herbal Plant Synthesis of Antibacterial Silver Nanoparticles by Solanum trilobatum and Its Characterization. Int J Met 2014;2014:692461 View Article
  17. Yang XX, Li CM, Huang CZ. Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale 2016;8(5):3040-3048 View Article PubMed/NCBI
  18. Kumari A, Kumar V, Yadav SK. Nanotechnology: A tool to enhance therapeutic values of natural plant products. Trends Med Res 2012;7:34-42
  19. Bhadoriya SS, Mangal A, Madoriya N, Dixit P. Bioavailability and bioactivity enhancement of herbal drugs by “Nanotechnology”: A review. J Current Pharm Res 2011;8(1):1-7
  20. Hano C, Abbasi BH. Plant-Based Green Synthesis of Nanoparticles: Production, Characterization and Applications. Biomolecules 2021;12(1):31 View Article PubMed/NCBI
  21. Nath D, Banerjee P. Green nanotechnology - A new hope for medical biology. Environ Toxicol Pharmacol 2013;36(3):997-1014 View Article PubMed/NCBI
  22. Razavi M, Salahinejad E, Fahmy M, Yazdimamaghani M, Vashaee D, Tayebi L. Green Processes for Nanotechnology. Berlin: Springer; 2015, 207-235
  23. Narayanan KB, Sakthivel N. Green synthesis of biogenic metal nanoparticles by terrestrial and aquatic phototrophic and heterotrophic eukaryotes and biocompatible agents. Adv Colloid Interface Sci 2011;169(2):59-79 View Article PubMed/NCBI
  24. Kuppusamy P, Yusoff MM, Maniam GP, Govindan N. Biosynthesis of metallic nanoparticles using plant derivatives and their new avenues in pharmacological applications - An updated report. Saudi Pharm J 2016;24(4):473-484 View Article PubMed/NCBI
  25. Iravani S. Green synthesis of metal nanoparticles using plants. Green Chem 2011;13:2638-2650
  26. Kharissova OV, Dias HV, Kharisov BI, Pérez BO, Pérez VM. The greener synthesis of nanoparticles. Trends Biotechnol 2013;31(4):240-248 View Article PubMed/NCBI
  27. Sankar R, Manikandan P, Malarvizhi V, Fathima T, Shivashangari KS, Ravikumar V. Green synthesis of colloidal copper oxide nanoparticles using Carica papaya and its application in photocatalytic dye degradation. Spectrochim Acta A Mol Biomol Spectrosc 2014;121:746-750 View Article PubMed/NCBI
  28. Sharma M. Applications of nanotechnology-based dosage forms for delivery of herbal drugs. Res Rev J Pharm Nanotechnol 2014;2:23-30
  29. Ansari MA, Khan HM, Alzohairy MA, Jalal M, Ali SG, Pal R, et al. Green synthesis of Al2O3 nanoparticles and their bactericidal potential against clinical isolates of multi-drug resistant Pseudomonas aeruginosa. World J Microbiol Biotechnol 2015;31(1):153-164 View Article PubMed/NCBI
  30. Arulanandraj N, Dhivya S, Gopal V. A review on herbal panoparticles. PharmaTutor 2018;6:32-37
  31. Chidambaram M, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations. J Pharm Pharm Sci 2011;14(1):67-77 View Article PubMed/NCBI
  32. Sato Y, Matsui H, Yamamoto N, Sato R, Munakata T, Kohara M, et al. Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus. J Control Release 2017;266:216-225 View Article PubMed/NCBI
  33. Grill AE, Johnston NW, Sadhukha T, Panyam J. A review of select recent patents on novel nanocarriers. Recent Pat Drug Deliv Formul 2009;3(2):137-142 View Article PubMed/NCBI
  34. Venugopal J, Prabhakaran MP, Low S, Choon AT, Deepika G, Dev VR, et al. Continuous nanostructures for the controlled release of drugs. Curr Pharm Des 2009;15(15):1799-1808 View Article PubMed/NCBI
  35. Chorilli M, Brizante AC, Rodrigues CA, Salgado HRN. Aspectos gerais em sistemas transdérmicos de liberação de fármacos. Rev Bras Farm 2007;88:7-13
  36. Parvez MK, Parveen S. Evolution and Emergence of Pathogenic Viruses: Past, Present, and Future. Intervirology 2017;60(1-2):1-7 View Article PubMed/NCBI
  37. Dey P, Vaijayanthimala S, Dalvi VS, Jain A, Gola D, Bajpai M, et al. COVID-19: Understanding the Pandemic Emergence, Impact and Infection Prevalence Worldwide. J Pure Appl Microbiol 2020;14(4):2235-2251 View Article
  38. Chattopadhyay D, Sarkar MC, Chatterjee T, Sharma Dey R, Bag P, Chakraborti S, et al. Recent advancements for the evaluation of anti-viral activities of natural products. N Biotechnol 2009;25(5):347-368 View Article PubMed/NCBI
  39. Papp I, Sieben C, Ludwig K, Roskamp M, Böttcher C, Schlecht S, et al. Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small 2010;6(24):2900-2906 View Article PubMed/NCBI
  40. Wei J, Zheng L, Lv X, Bi Y, Chen W, Zhang W, et al. Analysis of influenza virus receptor specificity using glycan-functionalized gold nanoparticles. ACS Nano 2014;8(5):4600-4607 View Article PubMed/NCBI
  41. Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res 2014;28(9):1275-1283 View Article PubMed/NCBI
  42. Sharma P, Sharma N, Neelam N. Optical properties of aluminium oxide nanoparticles synthesized by leaf extract of Ocimum sanctum. J Nanosci Nanotechnol 2019;5(4):817-819 View Article
  43. Haggag EG, Elshamy AM, Rabeh MA, Gabr NM, Salem M, Youssif KA, et al. Antiviral potential of green synthesized silver nanoparticles of Lampranthus coccineus and Malephora lutea. Int J Nanomedicine 2019;14:6217-6229 View Article PubMed/NCBI
  44. Melk MM, El-Hawary SS, Melek FR, Saleh DO, Ali OM, El Raey MA, et al. Antiviral Activity of Zinc Oxide Nanoparticles Mediated by Plumbago indica L. Extract Against Herpes Simplex Virus Type 1 (HSV-1). Int J Nanomedicine 2021;16:8221-8233 View Article PubMed/NCBI
  45. Fouda A, Al-Otaibi WA, Saber T, AlMotwaa SM, Alshallash KS, Elhady M, et al. Antimicrobial, Antiviral, and In-Vitro Cytotoxicity and Mosquitocidal Activities of Portulaca oleracea-Based Green Synthesis of Selenium Nanoparticles. J Funct Biomater 2022;13(3):157 View Article PubMed/NCBI
  46. Fatima M, Zaidi NU, Amraiz D, Afzal F. In Vitro Antiviral Activity of Cinnamomum cassia and Its Nanoparticles Against H7N3 Influenza A Virus. J Microbiol Biotechnol 2016;26(1):151-9 View Article PubMed/NCBI
  47. Sharma V, Kaushik S, Pandit P, Dhull D, Yadav JP, Kaushik S. Green synthesis of silver nanoparticles from medicinal plants and evaluation of their antiviral potential against chikungunya virus. Appl Microbiol Biotechnol 2019;103(2):881-891 View Article PubMed/NCBI
  • Future Integrative Medicine
  • pISSN 2993-5253
  • eISSN 2835-6357
Back to Top

Phytosynthesized Nanoparticles Against Viral Diseases: Current Updates

Mohammad K. Parvez, Sarfaraz Ahmed
  • Reset Zoom
  • Download TIFF